Influenza
1,387
54
87
1,115
Key Insights
Highlights
Success Rate
96% trial completion (above average)
Published Results
463 trials with published results (33%)
Research Maturity
1115 completed trials (80% of total)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 17/100
3.1%
43 terminated out of 1387 trials
96.3%
+9.7% vs benchmark
36%
499 trials in Phase 3/4
42%
463 of 1115 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 1115 completed trials
Clinical Trials (1387)
BPL-1357 Against H1N1 Influenza Virus Challenge
Longitudinal Deep Phenotyping of Central Mechanisms in Dysosmia: A Pilot Study Using Electrobulbogram (EBG), Functional MRI (fMRI), and Diffusion-Weighted Imaging (DWI)
pH1N1 Blinded Challenge Study
A Phase IV Study to Evaluate the Immune Responses of Subunit Influenza Vaccine in Healthy Adults
High vs. Standard Dose Influenza Vaccine in Adult SOT Recipients
Assess Safety and Immunogenicity of A/H5 Inactivated Monovalent Influenza Vaccines at Different Antigen Dose Levels Adjuvanted With AS03 or MF59
Clinical Outcomes and Pharmacotherapy Effectiveness in the VA Health Care System (COPE-VA)
Abbott ID NOW Point-of-Care Testing
Equity Evaluation of Fact Boxes on Informed COVID-19 and Influenza Vaccination Decisions - Study Protocol
Communication Intervention to Improve Influenza Vaccination Rates Among Elderly in Can Tho
Live Attenuated Influenza Vaccine as a Nasal Model for Influenza Infection
Safety and Immunogenicity of Chimeric Hemagglutinin mRNA Vaccine Candidates
A Surveillance Study of Susceptibility to Baloxavir Marboxil in Pediatric Participants With Influenza and Transmission of Influenza to Household Contacts
High vs.Standard Dose Influenza Vaccine in Pediatric Solid Organ Transplant (SOT) Recipients
Effect of Surgical Masks in Preventing Acute Respiratory Infections
Phase I Clinical Trial of Influenza Vaccine (Split Virion), Inactivated (High Dose)
Immune Responses to Dengue and Sepsis
Screening for LID Clinical Studies Unit Healthy Volunteer Protocols
H1ssF Flu Vaccine Clinical Trial
A Phase IV Clinical Trial of Influenza Vaccine (Split Virion), Inactivatedin (Anflu®) Pregnant Women (AnFLU-PREG)